Cre-lox mediated conditional removal of myeloid cell-derived Mif in a mouse model of oral cancer. by Siddiqui, Arham
Arham Siddiqui
CRE-LOX MEDIATED 
CONDITIONAL REMOVAL OF 
MYELOID CELL-DERIVED Mif
IN A MOUSE MODEL OF 
ORAL CANCER.
CRE-LOX MEDIATED CONDITIONAL REMOVAL OF MYELOID CELL-
DERIVED Mif IN A MOUSE MODEL OF ORAL CANCER.
A R H A M  M .  S I D D I Q U I ,  N A T H A N  R Y A N ,  K E L V I N  A N D E R S O N ,  G R E T A  V O L P E D O ,  L A U R E N  M E L L E N ,  S T E V E  O G H U M U  
P H D ,  A B H A Y  S A T O S K A R  M D ,  P H D
Oral cancer affects people globally with an estimated 657,000 new cases and 330,000 deaths yearly. Macrophage 
migration inhibitory factor (Mif) is a gene that encodes for a cytokine involved in regulating cell-mediated immunity, 
immunoregulation, and inflammation. Previous research has demonstrated that global Mif inhibition results in reduced 
oral cancer development. This was associated with a decrease in the accumulation of myeloid cell populations in the 
oral tumor microenvironment. Therefore, our group is interested in elucidating the role of Mif expression by myeloid 
populations in the oral tumor microenvironment. We previously generated floxed Mif reporter mice (Mif Fl/Fl). 
Selective breeding between Mif Fl/Fl mice and Cre knock-in mice driven by the Lysozyme promoter (Lyz-Cre) was 
performed to produce progeny with Mif deficiency in myeloid cells. Genotypic characterization for Mif Fl/Fl and Lyz-Cre
was performed by PCR of genomic DNA extracted from mouse ear tissue. Phenotypic characterization of myeloid 
Mif deficiency was performed through flow cytometric analysis on various myeloid cell populations. Selective 
breeding of the Mif Fl/Fl mice with the Lyz-Cre mice for three generations yielded myeloid-specific Mif deficient mice. 
Genotypic PCR characterization of Mif Fl/Fl mice yielded band sizes of 404 bp while wild-type mice yielded a band size 
of 221 bp. Furthermore, genotypic characterization of Lyz-Cre mice yielded a band size of 700 bp while wild-type mice 
yielded a band size of 350 bp. Phenotypic flow cytometric analysis of bone marrow-derived macrophages and 
peritoneal macrophages from myeloid-specific Mif deficient mice revealed absence of Mif expression in these cells. 
Furthermore, in these mice, this difference was not observed in lymphoid cells. Our data indicate that, using the Cre-
LoxP system and selective breeding conditional Mif gene removal in myeloid cells in mice can be achieved to help us 
gain a better understanding of the role Mif plays in the context of oral cancer and other inflammatory diseases.
2
BACKGROUND
• Oral Cancer, 657,000 new cases and 330,000 deaths yearly1
• Reduction of inflammation for those with cancer is beneficial
• Macrophage migration inhibitory factor (Mif) 
• Regulates cell-mediated immunity, immunoregulation, and inflammation
• Systemic inhibition leads to better prevention, prognoses and a decrease in tumor promoting myeloid-derived cell populations2
• The Cre recombinase and loxP system
• LoxP sequence is inserted to flank the Mif gene, aka floxxed
• Cre recombinase dimerizes with loxP and removes targeted Mif gene
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METHODS




• Flow Cytometric Analysis
• Myeloid derived cells
• Bone Marrow Derived Macrophages (BMDMs)























(12.5% of mice yielded 
this genotype)
(6.3% of mice yielded 
this genotype)
F3 Mif fl/flCre +/-
Mif fl/fl
Cre -/-
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(50% of mice yielded 
this genotype)
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RESULTS – GENOTYPIC 
CHARACTERIZATION
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§ Examples of each genotype
§ Cre expected bands
§ WT 350 bp
§ Lyz-Cre Mutant 700 bp
§ Mif Expected bands
§ WT Mif 221 bp
§ Mif fl 404 bp


















MIFfl/fl Lyz-Cre+/+ Myeloid KO
MIF Global KO Control
BMDMs
§ CD4 cells showed no 
difference in Mif from WT
§ Myeloid-derived BMDMs did 
have a decrease in Mif
MIF+/+ WT Control
MIFfl/fl Lyz-Cre+/+ Myeloid KO
MIF Global KO Control
CONCLUSIONS
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